Journal profile · HEMATOLOGY

Case Reports in Hematology

ISSN 2090-6560 · eISSN 2090-6579 · John Wiley & Sons, Inc. · USA

Case Reports in Hematology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.7 (journal website); fully open access; APC about USD 960; median 207 days to acceptance (112 articles, last 24 months); acceptance rate 41% (journal website); 70 articles in 2025; indexed in ESCI.

Impact factor0.7From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time207 daysMedian, submission to acceptance · 112 articles, last 24 months · Crossref
APCUSD 960Fully open access
Acceptance41%From the journal's website
Articles per year702025 · OpenAlex count

Scope

Aims, scope and focus

Case Reports in Hematology is published by John Wiley & Sons, Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research, together about 27.7% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)

Case Reports in Hematology is an open access journal publishing case reports and case series in all areas of hematology, including general hematology, pathology, and oncology, with a specific focus on lymphomas and leukemias.

From the journal's Aims & Scope

Research area (LetPub): HEMATOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Lymphoma Diagnosis and TreatmentMedicine10.6%
  2. Acute Myeloid Leukemia ResearchMedicine8.7%
  3. Chronic Lymphocytic Leukemia ResearchMedicine8.5%
  4. Chronic Myeloid Leukemia TreatmentsMedicine6%
  5. Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.4%
  6. Viral-associated cancers and disordersMedicine5.2%
  7. Eosinophilic Disorders and SyndromesMedicine5%
  8. Platelet Disorders and TreatmentsMedicine4.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorHematologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorHematologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
0.7Publisher website ·
h-index
24OpenAlex ·
i10-index
198OpenAlex ·
2-year mean citedness
0.42OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
69LetPub ·

Articles by year OpenAlex count · 1,079 in total · the current year is incomplete

YearArticlesOpen accessCitations
202610910913
2025707025
2024404054
2023313174
20225959237
20215656244

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

207 daysMedian, submission to acceptance · P25–P75 136 days – 280 days

Acceptance to online
median 24 days (112 articles)
Submission to online
median 233 days
Sample
112 articles with submission and acceptance dates (168 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 13 weeksLetPub ·
Acceptance rate (publisher)
41%Publisher website ·
Submission to first decision
90 daysPublisher website ·
Submission to publication (journal-reported)
about 13 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 960 / GBP 640 / EUR 830YesCC BY
OpenAlexUSD 870 / EUR 750 / GBP 640——
LetPubUSD 725Yes—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare6 items from the author guidelines
Abstract
≤ 300 words
Reference style
Chicago
Templates
Word
First submission
Free format: the journal's layout is not required
Highlights
Optional
Graphical abstract
Optional
Publisher website · model-extracted, each line checked against the text
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
Authorship Title and authorship information

The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…

Source ↗Publisher website ·
Conflicts of interest Conflicts of interest

Concurrent submission limit: three manuscripts Model summary

Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…

Source ↗Publisher website ·
Data availability Data availability

Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.

Source ↗Publisher website ·
License & copyright Copyright and permissions

Copyright: authors retain copyright, CC BY Model summary

Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…

Source ↗Publisher website ·
Open access

Open access journal publishing case reports and case series in all areas of hematology, including general hematology, pathology, and oncology, with a specific focus on lymphomas and leukemias. Model summary

Case Reports in Hematology is an open access journal publishing case reports and case series in all areas of hematology, including general hematology, pathology, and oncology, with a specific focus on lymphomas and leukemias.

Source ↗Publisher website ·
Peer review Peer review

Peer review model: single-anonymized Model summary

The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…

Source ↗Publisher website ·
Preprints Preprints

Preprint policy: preprints accepted Model summary

The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.

Source ↗Publisher website ·
Trial registration / reporting guidelines Reporting guidelines

Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
John Wiley & Sons, Inc.
Country or region
USA
Language
English
ISSN
2090-6560
Electronic ISSN
2090-6579
Official links

FAQ

Frequently asked questions about Case Reports in Hematology

What CAS zone is Case Reports in Hematology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Case Reports in Hematology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Case Reports in Hematology?

The journal's website gives an impact factor of 0.7; this is the journal's own figure, as LetPub lists none for it; h-index 24.

How long does peer review take at Case Reports in Hematology?

Based on the dates recorded on 112 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 207 days (interquartile range 136–280 days); authors report an average review time of about 13 weeks; the journal's website gives an acceptance rate of 41%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Case Reports in Hematology?

According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago; Templates: Word; First submission: Free format: the journal's layout is not required; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Which databases index Case Reports in Hematology?

According to LetPub and DOAJ records, Case Reports in Hematology is indexed in ESCI and DOAJ.

Is Case Reports in Hematology open access, and what is the APC?

Case Reports in Hematology is a fully open-access journal. APC about USD 960.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .